In the latest session, P10 Inc (NYSE: PX) closed at $8.33 down -10.14% from its previous closing price of $9.27. In other words, the price has decreased by -$0.94 from its previous closing price. On the day, 3332178 shares were traded.
Ratios:
For a deeper understanding of P10 Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 43.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.81. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Keefe Bruyette on March 01, 2024, Downgraded its rating to Mkt Perform and sets its target price to $10 from $12 previously.
On March 01, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $15.50 to $9.50.
On August 31, 2022, Barclays started tracking the stock assigning a Overweight rating and target price of $15.Barclays initiated its Overweight rating on August 31, 2022, with a $15 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 27 when Feinglass Michael sold 30,000 shares for $10.10 per share. The transaction valued at 303,144 led to the insider holds 397,496 shares of the business.
Nelson Andrew Rowan sold 8,403 shares of PX for $86,471 on Dec 19. The now owns 29,307 shares after completing the transaction at $10.29 per share. On Dec 14, another insider, Abell Alexander I., who serves as the of the company, sold 17,496 shares for $10.03 each. As a result, the insider received 175,512 and left with 400,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PX now has a Market Capitalization of 974.25M and an Enterprise Value of 1.24B. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.11 while its Price-to-Book (P/B) ratio in mrq is 2.50. Its current Enterprise Value per Revenue stands at 5.22 whereas that against EBITDA is 24.74.
Stock Price History:
Over the past 52 weeks, PX has reached a high of $13.41, while it has fallen to a 52-week low of $8.30. The 50-Day Moving Average of the stock is 9.22, while the 200-Day Moving Average is calculated to be 10.47.
Shares Statistics:
For the past three months, PX has traded an average of 703.48K shares per day and 920.2k over the past ten days. A total of 42.37M shares are outstanding, with a floating share count of 41.20M. Insiders hold about 64.77% of the company’s shares, while institutions hold 27.48% stake in the company. Shares short for PX as of Feb 15, 2024 were 3.21M with a Short Ratio of 4.57, compared to 3.53M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.75% and a Short% of Float of 6.68%.
Dividends & Splits
According to the company, the forward annual dividend rate for PX is 0.13, from 0.12 in the trailing year. Against a Trailing Annual Dividend Yield of 1.35%, it implies a Forward Annual Dividend Yield of 1.56%.
Earnings Estimates
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.21 for the current quarter, with a high estimate of $0.22 and a low estimate of $0.2, while EPS last year was $0.21. The consensus estimate for the next quarter is $0.23, with high estimates of $0.24 and low estimates of $0.22.
Analysts are recommending an EPS of between $0.98 and $0.89 for the fiscal current year, implying an average EPS of $0.94. EPS for the following year is $1.13, with 6 analysts recommending between $1.2 and $1.02.
Revenue Estimates
A total of 3 analysts believe the company’s revenue will be $61.65M this quarter.It ranges from a high estimate of $63.4M to a low estimate of $59.45M. As of the current estimate, P10 Inc’s year-ago sales were $57.25M, an estimated increase of 7.70% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $64.66M, an increase of 3.50% less than the figure of $7.70% in the same quarter last year. There is a high estimate of $66.1M for the next quarter, whereas the lowest estimate is $62.08M.
A total of 7 analysts have provided revenue estimates for PX’s current fiscal year. The highest revenue estimate was $274.46M, while the lowest revenue estimate was $254.61M, resulting in an average revenue estimate of $265.74M. In the same quarter a year ago, actual revenue was $241.73M, up 9.90% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $300.26M in the next fiscal year. The high estimate is $319.1M and the low estimate is $266.02M. The average revenue growth estimate for next year is up 13.00% from the average revenue estimate for this year.
